Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 6,098 | 9,550 | 10,343 | 16,803 | 13,697 |
| Operating Income | -6,098 | -9,550 | -10,343 | -16,803 | -13,697 |
| Interest Expense | 514 | 539 | 527 | 491 | 461 |
| Other Income | 1,859 | 1,902 | 1,883 | 1,679 | 1,255 |
| Pre-tax Income | -4,753 | -8,187 | -8,987 | -15,616 | -12,902 |
| Net Income Continuous | -4,753 | -8,187 | -8,987 | -15,616 | -12,902 |
| Net Income | $-4,753 | $-8,187 | $-8,987 | $-15,616 | $-12,902 |
| EPS Basic Total Ops | -0.08 | -0.14 | -0.15 | -0.27 | -0.22 |
| EPS Basic Continuous Ops | -0.08 | -0.14 | -0.15 | -0.27 | -0.22 |
| EPS Diluted Total Ops | -0.08 | -0.14 | -0.15 | -0.27 | -0.22 |
| EPS Diluted Continuous Ops | -0.08 | -0.14 | -0.15 | -0.27 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.14 | -0.15 | N/A | N/A |
| EBITDA(a) | $-6,031 | $-9,485 | $-10,278 | $-16,751 | $-13,651 |